+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

XELJANZ Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

XELJANZ Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Tocilizumab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Tocilizumab Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Crohn's Disease (CD) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Crohn's Disease (CD) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Uveitis Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Uveitis Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Ulcerative Colitis Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035) - Product Thumbnail Image

Ulcerative Colitis Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • Report
  • May 2026
  • 400 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Thumbnail Image

Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • April 2026
  • 150 Pages
  • Global
From
Psoriasis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Psoriasis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 120 Pages
  • Global
From
Ulcerative Colitis Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Type, Disease Type, Route of Administration, Distribution Channel - Product Thumbnail Image

Ulcerative Colitis Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Type, Disease Type, Route of Administration, Distribution Channel

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Psoriasis Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Type, Product Type, Route of Administration - Product Thumbnail Image

Psoriasis Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Type, Product Type, Route of Administration

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Inflammatory Bowel Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease (Crohn's Disease, Ulcerative Colitis), Drug Class, Molecule Type, Route of Administration - Product Thumbnail Image

Inflammatory Bowel Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease (Crohn's Disease, Ulcerative Colitis), Drug Class, Molecule Type, Route of Administration

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Fc Fusion Protein Market Outlook 2026-2034: Market Share, and Growth Analysis by Therapeutic Area (Autoimmune & Inflammatory, Ophthalmology, Hematology, Metabolic & Endocrine, Others), Route of Administration, Molecule Class - Product Thumbnail Image

Fc Fusion Protein Market Outlook 2026-2034: Market Share, and Growth Analysis by Therapeutic Area (Autoimmune & Inflammatory, Ophthalmology, Hematology, Metabolic & Endocrine, Others), Route of Administration, Molecule Class

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market: Strategic Landscape, Pipeline Innovations, and Economic Trajectories - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market: Strategic Landscape, Pipeline Innovations, and Economic Trajectories

  • Report
  • April 2026
  • 91 Pages
  • Global
From
Ulcerative Colitis Drug Market Outlook: Advanced Therapeutics, Pipeline Innovations, and Competitive Landscape - Product Thumbnail Image

Ulcerative Colitis Drug Market Outlook: Advanced Therapeutics, Pipeline Innovations, and Competitive Landscape

  • Report
  • April 2026
  • 99 Pages
  • Global
From
Inflammatory Bowel Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • July 2026
  • 120 Pages
  • Global
From
North America Psoriasis Treatment Market Outlook, 2031 - Product Thumbnail Image

North America Psoriasis Treatment Market Outlook, 2031

  • Report
  • March 2026
  • 88 Pages
  • North America
From
Middle East & Africa Psoriasis Treatment Market Outlook, 2031 - Product Thumbnail Image

Middle East & Africa Psoriasis Treatment Market Outlook, 2031

  • Report
  • March 2026
  • 80 Pages
  • Middle East, Africa
From
Asia-Pacific Psoriasis Treatment Market Outlook, 2031 - Product Thumbnail Image

Asia-Pacific Psoriasis Treatment Market Outlook, 2031

  • Report
  • March 2026
  • 107 Pages
  • Asia Pacific
From
Europe Psoriasis Treatment Market Outlook, 2031 - Product Thumbnail Image

Europe Psoriasis Treatment Market Outlook, 2031

  • Report
  • March 2026
  • 104 Pages
  • Europe
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more